|
GB884663A
(en)
|
1958-11-06 |
1961-12-13 |
Ciba Ltd |
New amines and processes for their manufacture
|
|
CH396941A
(de)
|
1959-08-10 |
1965-08-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer sekundärer Amine
|
|
GB1200886A
(en)
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3509153A
(en)
*
|
1967-03-24 |
1970-04-28 |
Miles Lab |
5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles
|
|
DE2710997C3
(de)
|
1977-03-14 |
1980-08-14 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US4569354A
(en)
|
1982-03-22 |
1986-02-11 |
Boston University |
Method and apparatus for measuring natural retinal fluorescence
|
|
ZA848004B
(en)
*
|
1983-10-19 |
1985-06-26 |
Hoffmann La Roche |
Phenoxypropanolamines
|
|
JPH0228112A
(ja)
|
1988-04-21 |
1990-01-30 |
Kaken Pharmaceut Co Ltd |
点眼用眼圧調整剤
|
|
US5135955A
(en)
|
1988-04-25 |
1992-08-04 |
Eli Lilly And Company |
Propanamine derivatives
|
|
IT1240427B
(it)
|
1990-03-02 |
1993-12-15 |
Ministero Dall Uni E Della Ric |
Arilpropilammine ad azione antifungina
|
|
EP0525360B1
(en)
|
1991-07-30 |
1998-03-25 |
Korea Research Institute Of Chemical Technology |
Novel phenylacetamide derivatives and processes for the preparation thereof
|
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
|
US5604229A
(en)
*
|
1992-10-21 |
1997-02-18 |
Yoshitomi Pharmaceutical Industries, Ltd. |
2-amino-1,3-propanediol compound and immunosuppressant
|
|
US5958973A
(en)
|
1993-09-03 |
1999-09-28 |
Gilead Sciences, Inc. |
Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
|
|
KR970700646A
(ko)
|
1994-01-19 |
1997-02-12 |
헤르베르트 루프·울리히 볼프 |
니트록시기를 포함한 벤질아민 유도체, 및 심장 혈관 질환과 안압 상승의 치료를 위한 이의 용도(nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure)
|
|
WO2001009327A2
(en)
|
1999-07-28 |
2001-02-08 |
Genentech, Inc. |
Method of preventing the injury or death of retinal cells and treating ocular diseases
|
|
US5541228A
(en)
|
1994-10-14 |
1996-07-30 |
Bristol-Myers Squibb Co. |
Melatonergic agents
|
|
US5693804A
(en)
*
|
1994-11-17 |
1997-12-02 |
Molecular Geriatrics Corporation |
Substituted 1-aryl-3-piperazin-1'-yl propanones
|
|
JPH0940646A
(ja)
*
|
1995-07-27 |
1997-02-10 |
Yamanouchi Pharmaceut Co Ltd |
ベンゼン縮合環誘導体又はその塩
|
|
US5641750A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
|
US6090624A
(en)
|
1996-04-19 |
2000-07-18 |
Brown University Research Foundation |
Immortalized retinal cell lines and their applications
|
|
FR2747690B1
(fr)
|
1996-04-19 |
1998-06-12 |
Neurotech Sa |
Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques
|
|
US6878544B2
(en)
|
1996-04-19 |
2005-04-12 |
Neurotech Sa |
Retinal cell lines with extended life-span and their applications
|
|
AUPO235996A0
(en)
|
1996-09-16 |
1996-10-10 |
Garvan Institute Of Medical Research |
Method of cell culture
|
|
CA2216439A1
(en)
|
1996-09-25 |
1998-03-25 |
Derek Van Der Kooy |
Pharmaceuticals containing retinal stem cells
|
|
DE19643592A1
(de)
|
1996-10-22 |
1998-04-23 |
Bayer Ag |
Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
|
|
US6713300B1
(en)
|
1997-02-27 |
2004-03-30 |
University Of Utah Research Foundation |
Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter
|
|
TW593331B
(en)
|
1997-07-25 |
2004-06-21 |
Inspire Pharmaceuticals Inc |
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
|
|
US6051605A
(en)
|
1997-08-08 |
2000-04-18 |
Warner-Lambert Company |
Method of treating psychosis and schizophrenia
|
|
US6171837B1
(en)
|
1997-09-29 |
2001-01-09 |
The Trustees Of Columbia University In The City Of New York |
Mouse and human 9-cis-retinol dehydrogenase
|
|
AU1996599A
(en)
|
1997-12-05 |
1999-06-28 |
Board Of Trustees Of The Leland Stanford Junior University |
Long-term survival and regeneration of central nervous system neurons
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
IL143382A0
(en)
|
1999-01-05 |
2002-04-21 |
Aventis Pharma Sa |
Human adult astrocytes, their preparation and uses thereof
|
|
EP1107003A1
(en)
|
1999-12-09 |
2001-06-13 |
Trophos |
Methods for screening compounds active on neurons
|
|
US6406840B1
(en)
|
1999-12-17 |
2002-06-18 |
Biomosaic Systems, Inc. |
Cell arrays and the uses thereof
|
|
CA2393466C
(en)
|
1999-12-21 |
2010-01-19 |
Gpi Nil Holdings, Inc. |
Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
|
|
CA2397194C
(en)
*
|
2000-01-20 |
2011-05-17 |
Mark E. Duggan |
Alpha v integrin receptor antagonists
|
|
WO2001083714A2
(en)
|
2000-05-02 |
2001-11-08 |
Central Institute For The Deaf |
Composition and methods for treating photoreceptor degeneration
|
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
|
WO2002006268A1
(en)
*
|
2000-07-13 |
2002-01-24 |
Sankyo Company, Limited |
Amino alcohol derivatives
|
|
JP2002167382A
(ja)
*
|
2000-07-13 |
2002-06-11 |
Sankyo Co Ltd |
アミノアルコ−ル誘導体
|
|
JP2002053575A
(ja)
*
|
2000-08-09 |
2002-02-19 |
Sankyo Co Ltd |
アミノアルコ−ル類
|
|
US20030032078A1
(en)
|
2001-01-23 |
2003-02-13 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of macular and retinal degenerations
|
|
DE10141018A1
(de)
|
2001-08-22 |
2003-03-13 |
Eth Zuerich Eidgenoessische Te |
Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
|
|
BR0306811A
(pt)
*
|
2002-01-11 |
2004-10-26 |
Sankyo Co |
Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
|
|
JP4771511B2
(ja)
*
|
2003-07-08 |
2011-09-14 |
第一三共株式会社 |
アミノアルコ−ル誘導体又はホスホン酸誘導体を含有する医薬組成物
|
|
JP2006506970A
(ja)
|
2002-07-12 |
2006-03-02 |
ユニバーシティ オブ ワシントン |
神経細胞の延長されたインビトロ培養のための方法および系
|
|
DE10235312A1
(de)
|
2002-08-01 |
2004-02-12 |
Basf Ag |
Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
|
|
US20060089343A1
(en)
|
2002-12-06 |
2006-04-27 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
|
|
NZ541828A
(en)
*
|
2003-03-04 |
2008-06-30 |
Pfizer Prod Inc |
Use of EP2 selective receptor agonists in medical treatment
|
|
US20040242704A1
(en)
|
2003-03-14 |
2004-12-02 |
University Of Washington, Techtransfer - Invention Licensing |
Stabilized mutant opsin proteins
|
|
EP1649009A2
(en)
|
2003-07-30 |
2006-04-26 |
Acucela, Inc. |
Extended primary retinal cell culture and stress models, and methods of use
|
|
EP1661881B1
(en)
|
2003-08-29 |
2014-12-17 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding s1p receptor and pharmaceutical use thereof
|
|
US7706863B2
(en)
|
2004-01-21 |
2010-04-27 |
University Of Washington |
Methods for assessing a physiological state of a mammalian retina
|
|
US7566808B2
(en)
|
2004-02-17 |
2009-07-28 |
President And Fellows Of Harvard College |
Management of ophthalmologic disorders, including macular degeneration
|
|
BR122020017756B1
(pt)
*
|
2004-08-26 |
2022-02-15 |
Pfizer Inc |
Uso de compostos de aminoeteroarila enantiomericamente puros na preparação de um medicamento para o tratamento de crescimento celular anormal em um mamífero
|
|
TWI359810B
(en)
|
2004-11-04 |
2012-03-11 |
Mitsubishi Tanabe Pharma Corp |
Carboxylic acid derivative containing thiazole rin
|
|
US20060252107A1
(en)
|
2005-02-22 |
2006-11-09 |
Acucela, Inc. |
Compositions and methods for diagnosing and treating retinal diseases
|
|
WO2006101102A1
(ja)
*
|
2005-03-22 |
2006-09-28 |
Kyowa Hakko Kogyo Co., Ltd. |
固形腫瘍治療剤
|
|
US8098907B2
(en)
|
2005-07-01 |
2012-01-17 |
Siemens Corporation |
Method and system for local adaptive detection of microaneurysms in digital fundus images
|
|
TW200744567A
(en)
|
2005-09-23 |
2007-12-16 |
Alcon Inc |
Phenylethylamine analogs and their use for treating glaucoma
|
|
NZ567858A
(en)
|
2005-11-01 |
2011-08-26 |
Array Biopharma Inc |
Pyridine compounds useful as Glucokinase activators
|
|
UA96283C2
(uk)
*
|
2005-12-23 |
2011-10-25 |
Зіланд Фарма А/С |
Модифіковані міметики лізину
|
|
WO2007079593A1
(en)
|
2006-01-13 |
2007-07-19 |
Mcgill University |
Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
|
|
WO2007120528A2
(en)
|
2006-03-31 |
2007-10-25 |
La Jolla Pharmaceutical Company |
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
|
|
KR101495611B1
(ko)
*
|
2006-04-07 |
2015-02-25 |
메틸진 인코포레이티드 |
히스톤 데아세틸라아제의 억제제
|
|
CN101443348A
(zh)
*
|
2006-05-23 |
2009-05-27 |
Irm责任有限公司 |
作为通道活化蛋白酶抑制剂的化合物和组合物
|
|
US8642612B2
(en)
*
|
2006-07-18 |
2014-02-04 |
Potomac Pharmaceuticals, Inc. |
Nicotinic desensitizers and methods of selecting, testing, and using them
|
|
EP2059507B1
(en)
*
|
2006-07-28 |
2013-03-20 |
Pfizer Products Inc. |
Ep2 agonist
|
|
BRPI0810063A2
(pt)
|
2007-04-20 |
2014-10-14 |
Acucela Inc |
Composto, composição farmacêutica, e, métodos para modular fluxo de cromóforo em um ciclo retinóide, para tratar uma doença ou distúrbio oftálmico em um indivíduo, para inibir adaptação ao escuro em uma célula fotorreceptora de bastão da retina, para inibir regeneração de rodopsina em uma célula fotoreceptora de bastão da retina, para reduzir isquemia em um olho de um indivíduo, para inibir neovascularização na retina de um olho de um indivíduo, e para inibir degeneração de uma célula da retina em uma retina
|
|
TW200906389A
(en)
*
|
2007-05-25 |
2009-02-16 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition comprising of therapeutic or prophylactic agents for hepatitis
|
|
NZ601866A
(en)
|
2007-06-29 |
2013-12-20 |
Acucela Inc |
Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
|
|
US7973079B2
(en)
*
|
2007-09-27 |
2011-07-05 |
Revision Therapeutics, Inc. |
Methods and compounds for treating retinol-related diseases
|
|
MX2010003667A
(es)
*
|
2007-10-05 |
2010-09-28 |
Acucela Inc |
Compuestos alcoxi para el tratamiento de enfermedades.
|
|
CA2701286A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Achaogen, Inc. |
Carbacephem .beta.-lactam antibiotics
|
|
KR101270122B1
(ko)
|
2007-11-01 |
2013-05-31 |
어큐셀라 인코포레이티드 |
안과 질환 및 장애를 치료하기 위한 아민 유도체 화합물
|
|
WO2009113637A1
(ja)
*
|
2008-03-12 |
2009-09-17 |
東ソー株式会社 |
新規なチアゾール誘導体、チアゾール誘導体固定化マトリックス、及びそれらの製造方法
|
|
MX2011002448A
(es)
|
2008-09-05 |
2011-05-25 |
Acucela Inc |
Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos.
|
|
JP5773877B2
(ja)
|
2008-10-22 |
2015-09-02 |
アキュセラ インコーポレイテッド |
眼の疾患及び障害を治療する化合物
|
|
EP4000610A1
(en)
|
2009-07-02 |
2022-05-25 |
Acucela Inc. |
Pharmacology of visual cycle modulators
|
|
GB2474120B
(en)
*
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
HK1210969A1
(en)
|
2012-01-20 |
2016-05-13 |
奥克塞拉有限公司 |
Substituted heterocyclic compounds for disease treatment
|
|
TW201406707A
(zh)
|
2012-05-04 |
2014-02-16 |
Acucela Inc |
用以治療糖尿病性視網膜病變及其他眼部疾病之方法
|